4//SEC Filing
ENCORIUM GROUP INC 4
Accession 0001181431-07-048135
CIK 0000856569operating
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 2:42 PM ET
Size
9.0 KB
Accession
0001181431-07-048135
Insider Transaction Report
Form 4
Manninen Petri Mikael
Director
Transactions
- Exercise/Conversion
stock option
2007-07-25−48,099→ 0 totalExercise: $2.57From: 2006-11-01Exp: 2009-01-31→ common stock (48,099 underlying) - Exercise/Conversion
common stock
2007-07-25$2.57/sh+48,099$123,614→ 48,099 total
Holdings
- 273,403(indirect: managing director of NTGLT Pharma BVBA)
common stock
Footnotes (4)
- [F1]Prior to the Company's acquisition of Remedium on November 1, 2006, Mr. Manninen held an option to purchase 120 shares of Remedium. Pursuant to the terms of an option exchange agreement, upon the consummation of the Company's acquisition of Remedium on November 1, 2006, the option held by Mr. Manninen remained outstanding. Upon exercise, however, Mr. Manninen became entitled to receive approximately 400.82 Encorium shares for each Remedium share otherwise issuable upon the exercise of a Remedium option (or approximately 48,099 shares of Encorium stock) at an excercise price of 750 EUR per Remedium share. The EUR 750 exercise price per Remedium share represented an exercise price per Encorium share of $2.57, based on the exchange rate into the U.S. Dollar of the Euro designated by the Federal Reserve Bank of New York as of July 25, 2007.
- [F2]See Footnote 1.
- [F3]See Footnote 1.
- [F4]See Footnote 1.
Documents
Issuer
ENCORIUM GROUP INC
CIK 0000856569
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0000856569
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 2:42 PM ET
- Size
- 9.0 KB